| 摘要 |
The use of an agent which selectively inhibits, prevents or interferes with the signal transduced by flk-1/KDR when activated by a ligand, in the manufacture of a medicament for the treatment of lymphoedema and in a method for reducing the filtration rate from blood to tissue. Also provided is a method for identifying compounds useful in the treatment of lymphoedema, and compounds identified thereby.
|
